This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (64)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Efficacy and Diminishing Need During Successive Years of Treatment

Stephen E. Straus, MD; Kenneth D. Croen, MD; Mark H. Sawyer, MD; Alison G. Freifeld, MD; James M. Felser, MD; Janet K. Dale, RN; Holly A. Smith; Claire Hallahan, MS; Sandra Nusinoff Lehrman, MD

JAMA. 1988;260(15):2227-2230.

Abstract
Forty-seven patients with frequently recurring genital herpes participated in one or more of five sequential trials of oral suppressive therapy with 200 mg of acyclovir three times daily from four to 12 months' duration. The prolonged use of acyclovir was extremely well tolerated, and treatment efficacy was sustained through successive studies. Recurrences in eight patients with repeated treatment "failures" were more effectively suppressed with higher doses of acyclovir. All patients experienced recurrent infections after the treatments were completed; however, the mean time to recurrence following each treatment period became progressively longer, and resumption of suppressive therapy was no longer warranted for ten patients. These data indicate the efficacy and safety of chronic suppressive therapy with acyclovir and the value of interrupting prolonged treatment to assess its further need.

(JAMA 1988;260:2227-2230)

Author Affiliations
From the Medical Virology Section, Laboratory of Clinical Investigation, and the Office of the Director, Intramural Research Program, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Md (Drs Straus, Croen, Sawyer, Freifeld, and Felser and Mss Dale, Smith, and Hallahan); and the Virology Division, Burroughs Wellcome Co, Research Triangle Park, NC (Dr Lehrman).

Footnotes
Reprint requests to the Medical Virology Section, Bldg 10, Room 11N113, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892 (Dr Straus).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Treatment of Herpes Simplex Infections: An Evidence-Based Review
Cernik et al.
Arch Intern Med 2008;168:1137-1144.
ABSTRACT | FULL TEXT  

Long-term Suppression of Recurrent Genital Herpes With Acyclovir: A 5-Year Benchmark
Goldberg et al.
Arch Dermatol 1993;129:582-587.
ABSTRACT  

Herpes Simplex Virus Associated With Recurrent Stevens-Johnson Syndrome: A Management Strategy
Detjen et al.
Arch Intern Med 1992;152:1513-1516.
ABSTRACT  

Prolonged Continuous Acyclovir Treatment of Normal Adults With Frequently Recurring Genital Herpes Simplex Virus Infection
Kaplowitz et al.
JAMA 1991;265:747-751.
ABSTRACT  

Sexually Transmitted Diseases
Albrecht and Wilkes
Journal of Pharmacy Practice 1991;4:237-246.
 

Antiviral Drugs in Pediatrics
Balfour and Englund
Arch Pediatr Adolesc Med 1989;143:1307-1316.
ABSTRACT  

LONG-TERM ACYCLOVIR FOR TREATING GENITAL HERPES
JWatch General 1988;1988:7-7.
FULL TEXT